Literature DB >> 29689240

Diagnosing Epithelioid Hemangioendothelioma With Pericardial Involvement.

Brianna E Balansay1, Xinyuan Zhang1, Patrick D Loftus2, Joy Aparicio Valenzuela1, Eduardo Zambrano3, Anson M Lee1.   

Abstract

Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor that commonly affects lung, liver, and bone. Among all known EHE cases, only 20% have a pulmonary origin, with metastases to the pericardium occurring in less than 1% of these. Because of its low prevalence, variable presentation, and unknown latency period, a thoracic EHE diagnosis can be easily missed. This case outlines the unique pathologic features of EHE in a patient with cardiovascular disease, provides further insight into diagnosing a rare tumor, and provides a better understanding of the pathophysiology and progression of thoracic EHE.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29689240     DOI: 10.1016/j.athoracsur.2018.03.045

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Response by Jung et al to Letter Regarding Article, "Sustained Activation of Endothelial YAP1 Causes Epithelioid Hemangioendothelioma".

Authors:  Roy Jung; Harish P Janardhan; Karen Dresser; Jennifer L Cotton; Lloyd Hutchinson; Junhao Mao; Chinmay M Trivedi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-09-22       Impact factor: 10.514

2.  Femoral epithelioid hemangioendothelioma detected with magnetic resonance imaging and positron emission tomography/computed tomography: A case report.

Authors:  Hong-Guang Zhao; Ke-Wei Zhang; Sen Hou; Yu-Yin Dai; Song-Bai Xu
Journal:  World J Clin Cases       Date:  2021-02-26       Impact factor: 1.337

3.  Prognostic Determinants Analysis and Nomogram for Bone Malignant Vascular Tumors: A Surveillance, Epidemiology and End Results (SEER) Analysis.

Authors:  Sunli Hu; Xiangyang Wang
Journal:  Med Sci Monit       Date:  2020-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.